UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044334
Receipt number R000050634
Scientific Title Research using samples and information in bone and soft tissue sarcoma resection at Gunma University Hospital Orthopedic Surgery
Date of disclosure of the study information 2021/05/26
Last modified on 2021/05/26 12:30:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research using samples and information in bone and soft tissue sarcoma resection at Gunma University Hospital Orthopedic Surgery

Acronym

Research using samples and information in bone and soft tissue sarcoma resection at Gunma University Hospital Orthopedic Surgery

Scientific Title

Research using samples and information in bone and soft tissue sarcoma resection at Gunma University Hospital Orthopedic Surgery

Scientific Title:Acronym

Research using samples and information in bone and soft tissue sarcoma resection at Gunma University Hospital Orthopedic Surgery

Region

Japan


Condition

Condition

Bone and soft tissue sarcoma

Classification by specialty

Orthopedics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to perform photoimmunotherapy (PIT) on tumor tissues and tumor cells resected during surgery in patients with bone and soft tissue sarcoma and to verify the therapeutic effect of PIT on bone and soft tissue sarcoma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The effect of photoimmunotherapy (PIT) on the tumor tissue resected when the primary bone and soft tissue tumor was resected will be examined. Regarding the effect of PIT, the number of surviving tumor cells after photoimmunotherapy and the size of transplanted tumor tissue are statistically analyzed.

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients diagnosed with primary bone and soft tissue tumor
2) Patients who will undergo tumor resection (including biopsy) at our hospital

Key exclusion criteria

1) Patients for whom consent was not obtained

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Koichi
Middle name
Last name Okamura

Organization

Gunma Univesrsity

Division name

Orthopaedic Surgery

Zip code

3718511

Address

3-39-22 Showamachi, Maebashi, Gunma

TEL

0272208269

Email

kokamura@gunma-u.ac.jp


Public contact

Name of contact person

1st name Office
Middle name
Last name Office

Organization

Gunma Univesrsity

Division name

IRB

Zip code

3718511

Address

3-39-15 Showamachi, Maebashi, Gunma

TEL

0272208740

Homepage URL


Email

ciru_hitotaisho-irb@ml.gunma-u.ac.jp


Sponsor or person

Institute

Gunma University

Institute

Department

Personal name



Funding Source

Organization

Gunma University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University

Address

3-39-15 Showamachi, Maebashi, Gunma

Tel

0272208740

Email

ciru_hitotaisho-irb@ml.gunma-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 12 Month 25 Day

Date of IRB

2020 Year 12 Month 25 Day

Anticipated trial start date

2020 Year 12 Month 25 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Tumor cells collected at the time of surgery are cultured, and the effect of photoimmunotherapy is confirmed on the cultured cells by animal experiments using in vitro and mice.


Management information

Registered date

2021 Year 05 Month 26 Day

Last modified on

2021 Year 05 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050634


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name